Purchase Order 75D30126P20893
- Not listed
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $56,000 firm fixed-price purchase order to Biolytic Lab Performance Inc. for maintenance services on a DR. OLIGO 48 DNA synthesizer. The contract was awarded on February 10, 2024, with an ultimate completion date of February 9, 2026, and no set-aside designation was used. Biolytic Lab Performance Inc., a veteran-owned corporation headquartered in Fremont, California, specializes in DNA synthesis solutions and advanced...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh has awarded a $56,160 firm fixed-price purchase order to Biolytic Lab Performance Inc., a veteran-owned laboratory equipment specialist based in Fremont, California, for annual maintenance services on DNA synthesizer systems. The contract, awarded on September 30, 2025, with an ultimate completion date of September 29, 2027, covers maintenance and support for the BLP 3900 and BLP Dr. Oligo 48 synthesizer systems. The procurement was...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order, contract number 75D30120P09399, to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for a maintenance agreement covering a Biolytic DNA synthesizer. The $28,100 contract has an ultimate completion date of August 16, 2023. The contract was awarded without a set-aside on August 17, 2020, based on a sole-source solicitation. Biolytic Lab Performance is the only company...
- This firm fixed-price purchase order was awarded to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The $54,000 contract is for the maintenance of a medium throughput DNA synthesizer and 42 related reagents. The award was not set aside for any specific business category. Biolytic Lab Performance Inc. specializes in providing scientific instrumentation, particularly oligonucleotide synthesizers...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for the procurement of a DR. OLIGO Synthesizer. The contract, valued at $84,950.00, has an ultimate completion date of April 30, 2020. Biolytic Lab Performance Inc. is a federal contractor that specializes in DNA synthesis solutions and laboratory equipment, and has secured multiple awards from various civilian and...
- This is a $95,700 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned for-profit company specializing in DNA synthesis solutions and laboratory equipment. The contract is for the procurement of a DR.OLIGO 48 DNA synthesizer, which allows the CDC to synthesize oligonucleotides at a much higher capacity with reduced turnaround time and argon gas consumption. This sole-source contract is based...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Biolytic Lab Performance Inc., a veteran-owned for-profit organization. The contract, valued at $84,950.00, is for the provision of an OLIGO INST (oligonucleotide instrument), with a performance period ending on July 20, 2021. The contract has no set-aside designation. Biolytic Lab Performance Inc. is a provider of DNA synthesis solutions and laboratory equipment, having secured...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded Biolytic Lab Performance Inc., a for-profit, veteran-owned business, a firm-fixed-price purchase order contract for $42,600.00. The contract is for an annual service agreement with a completion date of August 9, 2025. The original solicitation was for 500 mL of Avantor Seradigm Premium Grade Fetal Bovine Serum. This contract does not have a set-aside designation. Biolytic Lab Performance...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a definitive, firm fixed-price lab equipment maintenance agreement to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on July 3, 2024, with a ceiling value of $8.03 million and performance through June 30, 2029. This non-set-aside contract supports maintenance services for scientific laboratory equipment at the CDC's Atlanta, Georgia facility. Life Technologies Corporation is a leading manufacturer...
- The federal government awarded a $109,100 firm-fixed-price purchase order contract to Life Technologies Corporation, a subsidiary of parent company Thermo Electron Corporation, to provide biomedical research equipment, reagents, and associated services to the Centers for Disease Control and Prevention (CDC) Pittsburgh office. This contract is not associated with any set-aside designation. Life Technologies is an experienced provider of scientific instruments, consumables, and technical support...
The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $72,640 firm fixed-price purchase order to Biolytic Lab Performance Inc. for DNA synthesizer maintenance services. The contract, which carries an ultimate completion date of March 25, 2028, supports critical laboratory infrastructure at CDC facilities in Atlanta, Georgia. No set-aside designation was applied to this award. Biolytic Lab Performance Inc., a veteran-owned corporation based in Fremont, California, specializes in DNA synthesis solutions and laboratory equipment maintenance, with particular expertise in oligonucleotide synthesizers and related scientific instrumentation. Biolytic Lab Performance brings substantial relevant experience to this engagement, having maintained federal vendor registration since 2009 and accumulated approximately $697,570 in federal contracts across multiple agencies, including the CDC Pittsburgh, Office of Naval Research, Department of the Navy, and other research institutions. The company's service offerings typically encompass preventative and corrective maintenance, parts replacement, labor, travel expenses, and related support for DNA synthesizer systems. This maintenance contract aligns with CDC's operational requirements to sustain advanced molecular biology capabilities essential to disease detection, research, and public health initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.1k | 3/23/26 |